Variant report
Variant | nsv967519 |
---|---|
Chromosome Location | chr8:20760950-20764730 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:20750920..20753775-chr8:20759115..20761137,3 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs75098118 | chr8:20760989-20760990 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs564515949 | chr8:20760997-20760998 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs147214402 | chr8:20761060-20761061 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs577281196 | chr8:20761074-20761075 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs569328437 | chr8:20761075-20761076 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs140636251 | chr8:20761097-20761098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs562082177 | chr8:20761148-20761149 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs546383681 | chr8:20761189-20761190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs183059229 | chr8:20761203-20761204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs537187781 | chr8:20761250-20761251 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs547609908 | chr8:20761255-20761256 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs73627801 | chr8:20761287-20761288 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs527396356 | chr8:20761298-20761299 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs545095082 | chr8:20761339-20761340 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs551944311 | chr8:20761363-20761364 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs570525381 | chr8:20761368-20761369 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs187367781 | chr8:20761394-20761395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs73668274 | chr8:20761448-20761449 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs549787946 | chr8:20761513-20761514 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs4961417 | chr8:20761608-20761609 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs114816607 | chr8:20761632-20761633 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs144404064 | chr8:20761638-20761639 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs565698513 | chr8:20761641-20761642 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs73668275 | chr8:20761661-20761662 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs147414770 | chr8:20761668-20761669 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs576116735 | chr8:20761696-20761697 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs543444130 | chr8:20761711-20761712 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs192330740 | chr8:20761733-20761734 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs574016051 | chr8:20761738-20761739 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs553324683 | chr8:20761766-20761767 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs559906046 | chr8:20761767-20761768 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs116646743 | chr8:20761824-20761825 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs545575339 | chr8:20761825-20761826 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs564062459 | chr8:20761830-20761831 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs531412944 | chr8:20761856-20761857 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs577885155 | chr8:20761890-20761891 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs549824588 | chr8:20761909-20761910 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs577834606 | chr8:20761935-20761936 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs374209140 | chr8:20761958-20761959 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs77435400 | chr8:20762010-20762011 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs544960277 | chr8:20762012-20762013 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs184101618 | chr8:20762013-20762014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs187501039 | chr8:20762035-20762036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs547330469 | chr8:20762039-20762040 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs530920527 | chr8:20762057-20762058 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs564573149 | chr8:20762065-20762066 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs375621289 | chr8:20762095-20762096 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs537116674 | chr8:20762096-20762097 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs192770551 | chr8:20762101-20762102 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs116330127 | chr8:20762165-20762166 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Immune disease | 21572526 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Kallmann Syndrome 2 | 22470819 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Epilepsy | 22083797 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Bladder cancer | 21909424 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21364760 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cancer | 18840272 | CNVD |
Breast cancer | 19602461 | CNVD |
Osteosarcoma | 19286668 | CNVD |
Prostate cancer | 19242612 | CNVD |
Prostate cancer | 19258508 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Melanoma | 20688739 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:20760600-20761800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
2 | chr8:20760800-20761200 | Enhancers | Brain Inferior Temporal Lobe | brain |
3 | chr8:20761400-20764200 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
4 | chr8:20762400-20762600 | Enhancers | H9 Cell Line | embryonic stem cell |
5 | chr8:20763400-20763600 | Enhancers | H9 Cell Line | embryonic stem cell |
6 | chr8:20763400-20763800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
7 | chr8:20764200-20765000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |